ABR-PF(ABR-PF)
ABR-PF
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
No analyst price targets available for ABR-PF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $467M | $450M |
| Low | $439M | $336M |
| High | $494M | $500M |
| EBITDA Avg | $85M | $158M |
| Low | $72M | $128M |
| High | $93M | $174M |
| EBIT Avg | $67M | $143M |
| Low | $53M | $113M |
| High | $74M | $159M |
| Net Income Avg | $57M | $122M |
| Low | $45M | $97M |
| High | $64M | $136M |
| EPS Avg | $0.27 | $0.58 |
| Low | $0.22 | $0.46 |
| High | $0.30 | $0.65 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $115M | $112M | $106M | $112M | $116M | $121M |
| Low | $103M | $91M | $90M | $96M | $99M | $104M |
| High | $127M | $122M | $116M | $123M | $128M | $133M |
| EBITDA Avg | $17M | $23M | $31M | $35M | $40M | $45M |
| Low | $15M | $20M | $26M | $30M | $33M | $37M |
| High | $18M | $25M | $34M | $39M | $45M | $50M |
| EBIT Avg | $11M | $18M | $26M | $30M | $36M | $41M |
| Low | $9M | $14M | $21M | $25M | $29M | $33M |
| High | $13M | $20M | $29M | $34M | $40M | $46M |
| Net Income Avg | $10M | $15M | $22M | $26M | $31M | $35M |
| Low | $8M | $12M | $18M | $21M | $25M | $28M |
| High | $11M | $17M | $25M | $29M | $34M | $39M |
| EPS Avg | $0.05 | $0.08 | $0.12 | $0.14 | $0.16 | $0.18 |
| Low | $0.04 | $0.06 | $0.09 | $0.11 | $0.13 | $0.15 |
| High | $0.06 | $0.09 | $0.13 | $0.15 | $0.18 | $0.21 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 |